Growth hormone
CJC-1295
Clinical trials
3.90 reviewsPrimary purposes
Body composition, Sleep quality, Recovery
Relevant conditions
Low growth hormone
Mechanism of action
GHRH analog that extends growth hormone release; often combined with Ipamorelin.
Details
CJC-1295 raised GH and IGF-1 for days in early human trials. Development was halted and it is not approved.
Verified sources & manufacturers
Coming soon – we are building a list of verified studies and manufacturers. Learn more
Community experiences
Sign in to write reviews and share experiences.
No reviews yet – be the first.